The largest database of trusted experimental protocols

Clozapine dihydrochloride

Manufactured by Hello Bio
Sourced in United Kingdom, United States

Clozapine dihydrochloride is a chemical compound used as a laboratory reagent. It is the dihydrochloride salt form of the antipsychotic drug clozapine. Clozapine dihydrochloride is typically used in research and analytical applications.

Automatically generated - may contain errors

6 protocols using clozapine dihydrochloride

1

Neuronal Activation Modulates Attentional Shifting

Check if the same lab product or an alternative is used in the 5 most similar protocols
Three weeks after surgery, behavioral testing on the attentional set-shifting task began. Prior to testing, the DREADDS were activated by clozapine (Gomez et al. 2017 ; Tan et al. 2020 (link)) either by systemic injection (Experiment 1) or intracranial infusion (Experiment 2).
In Experiment 1, clozapine dihydrochloride (Hello Bio) was dissolved in sterile saline. Twenty minutes before the test began, all rats received an intraperitoneal (I.P.) injection of clozapine dihydrochloride at a dose of 4 mg/kg (as salt).
In Experiment 2, clozapine dihydrochloride (Hello Bio) was dissolved in sterile saline at a dose of 1 μg/μL (as salt). Fifteen minutes prior to testing, rats were lightly restrained, the obturators removed, and 33-gauge stainless steel infusion cannulae (Plastic One) that projected 2.0 mm beyond the tip of the guide cannulae were inserted. Each pair of infusion cannula was connected to two 5 μL Hamilton syringes (Bonaduz) mounted on 2 infusions pumps (Harvard Apparatus Ltd). A volume of 0.25 μL per hemisphere was infused over 1 min. The infusion cannulae were left in situ for a further 1 min to allow absorption of the bolus. The infusion cannulae were then removed and the obturators replaced.
+ Open protocol
+ Expand
2

Chemogenetic Modulation of Attention Shifting

Check if the same lab product or an alternative is used in the 5 most similar protocols
Three weeks post-surgery, behavioral testing on the attentional set-shifting task began.
Prior to testing, the DREADDS were activated by clozapine (Gomez et al., 2017; Tan et al., 2020) either by systemic injection (Experiment 1) or intracranial infusion (Experiment 2).
In Experiment 1, clozapine dihydrochloride (Hello Bio, Bristol, UK) was dissolved in sterile saline. Twenty minutes before the test began, all rats received an intraperitoneal (I.P.) injection of clozapine dihydrochloride at a dose of 4 mg/kg (as salt).
In Experiment 2, clozapine dihydrochloride (Hello Bio, Bristol, UK) was dissolved in sterile saline at a dose of 1 µg/µl (as salt). Fifteen minutes prior to testing, rats were lightly restrained, the obturators removed, and 33-gage stainless steel infusion cannulae (Plastic One, Roanoke, VA, USA) that projected 2.0 mm beyond the tip of the guide cannulae were inserted. Each pair of infusion cannula was connected to two 5 μl Hamilton syringes (Bonaduz, Switzerland) mounted on two infusions pumps (Harvard Apparatus Ltd, Kent, UK).
A volume of 0.25 μl per hemisphere was infused over 1 minute. The infusion cannulae were left in situ for a further 1 minute to allow absorption of the bolus. The infusion cannulae were then removed and the obturators replaced.
+ Open protocol
+ Expand
3

Rapid Neuronal Activation Mapping in Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
One week after the completion of behavioral testing, all rats received an I.P. injection of clozapine dihydrochloride (4 mg/kg as salt; HelloBio) to activate DREADDS in the experimental group. Each rat was placed individually in a cage in a dark holding room for 20 min, followed by 2 novel environments, each for 15 min. The first was a large square open field arena measuring 100 cm long, 100 cm wide, and 45 cm tall, which was filled with bedding sawdust and 6 novels objects. The second was a bow–tie maze (Albasser et al. 2010 (link)), which measured 120 cm long, 50 cm wide, and 50 cm tall, which was filled with bedding sawdust and food rewards (Cheerios, Nestle). Rats were then returned to the dark holding room for 90 min, to allow for neuronal Fos expression (Bisler et al. 2002 (link)) before perfusion.
+ Open protocol
+ Expand
4

Pharmacological Agents for Neuromodulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Clozapine N-oxide (CNO) dihydrochloride (water soluble) and clozapine dihydrochloride (water soluble) were purchased from Hello Bio Inc. (Princeton, NJ, USA). Scopolamine hydrobromide, Oxotremorine M, and aCSF were purchased from Tocris (Minneapolis, MN, USA). Stock solutions of drugs were made and working concentrations of the drugs were prepared freshly on the day of each experiment by appropriate dilutions of the stock solutions in aCSF.
+ Open protocol
+ Expand
5

Pharmacological Agents for Neuromodulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Clozapine N-oxide (CNO) dihydrochloride (water soluble) and clozapine dihydrochloride (water soluble) were purchased from Hello Bio Inc. (Princeton, NJ, USA). Scopolamine hydrobromide, Oxotremorine M, and aCSF were purchased from Tocris (Minneapolis, MN, USA). Stock solutions of drugs were made and working concentrations of the drugs were prepared freshly on the day of each experiment by appropriate dilutions of the stock solutions in aCSF.
+ Open protocol
+ Expand
6

Investigating DREADDS-Induced Neuronal Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
One week after the completion of behavioral testing, the in-vivo influence of DREADDs was investigated by comparing group differences in the expression of the immediate-early gene c-fos. This gene is an indirect marker of neuronal activity (Chaudhuri, 1997; Tischmeyer and Grimm, 1999; Guzowski et al., 2005) and is expressed in multiple brain regions, including the anterior cingulate cortex and anterior thalamic nuclei following exposure to novelty (Zhu et al., 1995; Vann et al., 2000; Wirtshafter, 2005) .
Rats received an I.P. injection of clozapine dihydrochloride (4mg/kg as salt; HelloBio, Bristol, UK) to activate DREADDS and were placed in a cage in a dark holding room for 20 minutes.
Rats were then were placed in two novel environments, each for 15 minutes. The first was a large square open field arena measuring 100cm long, 100cm wide and 45cm tall which was filled with bedding sawdust and six novels objects. The second was a bow-tie maze (Albasser et al., 2010) which measured 120cm long, 50cm wide and 50cm tall and was filled with bedding sawdust and food rewards (Cheerios, Nestle, Glasgow, UK). Rats were then returned to the dark holding room for 90 minutes, to allow for neuronal Fos expression (Bisler et al., 2002) before perfusion.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!